STAAR Surgical to Host “Vision 2026” Investor Day on September 14, 2023
07 Setembro 2023 - 6:00PM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses for the eye, today
announced that it will host an in-person Investor Day on Thursday,
September 14, 2023, beginning at 8:00 a.m. Eastern Time in New York
City.
The “Vision 2026” Investor Day will highlight key company
initiatives and projects including, several next generation product
pipeline initiatives, as well as the significant global growth
opportunities ahead for STAAR and its game-changing EVO ICL family
of lenses for vision correction. Several leading refractive
surgeons from around the world will speak to their experience with
EVO ICL and share feedback from delighted EVO patients who no
longer have to deal with the hassles of glasses and contact lenses
and the reasons they chose EVO ICL.
Vision 2026, the in-person meeting, will be held at the Nasdaq
MarketSite in New York and take place from 8:00 a.m. to 1 p.m.
Eastern Time. Advanced registration is required for in-person
attendance.
A taped replay of the event will be available at the “Investors”
section of the Company’s website.
Please contact Brian Moore at bmoore@staar.com with any
questions.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 40 years, designs, develops, manufactures and markets
implantable lenses for the eye. These lenses are intended to
provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are
foldable, which permits the surgeon to insert them through a small
incision. STAAR’s lens used in refractive surgery is called an
Implantable Collamer® Lens or “ICL”, which includes the EVO ICL™
product line. More than 2,000,000 ICLs have been sold to date and
STAAR markets these lenses in over 75 countries. To learn more
about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230907238444/en/
Investors & Media Brian Moore Vice President,
Investor, Media Relations and Corporate Development (626) 303-7902,
Ext. 3023 bmoore@staar.com
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024